Acute Gout Diagnosis Rule
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–4
- Intermediate Risk4.5–7.5
- High Risk8–13
The Acute Gout Diagnosis Rule calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include male sex. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Risk stratifies for gout vs non-gout arthritis and helps determine which patients benefit most from joint aspiration. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.
Clinical Indication
The Acute Gout Diagnosis Rule is indicated for bedside clinical practice to support Risk stratifies for gout vs non-gout arthritis and helps determine which patients benefit most from joint aspiration. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.
Limitations & Contraindications
Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.
Clinical Pearls & Action Plan
Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: NPV of 95% for scores <4 and PPV of 87% for scores ≥8 in validation study.
Score = (Male sex × 2) + (Previous arthritis attack × 2) + (Onset within 1 day × 0.5) + (Joint redness × 1) + (1st MTP involvement × 2.5) + (Hypertension/CVD × 1.5) + (Elevated uric acid × 3.5)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| male_sex | string | Yes | Patient's sex (male sex increases risk)(categorical) |
| previous_arthritis_attack | string | Yes | Previous patient-reported arthritis attack(categorical) |
| onset_within_one_day | string | Yes | Onset of symptoms within 1 day(categorical) |
| joint_redness | string | Yes | Joint redness present(categorical) |
| first_mtp_involvement | string | Yes | First metatarsophalangeal (MTP) joint involvement(categorical) |
| hypertension_or_cardiovascular | string | Yes | Hypertension or presence of ≥1 cardiovascular disease (angina, MI, CHF, stroke/TIA, PVD)(categorical) |
| elevated_uric_acid | string | Yes | Serum uric acid > 5.88 mg/dL (> 0.35 mmol/L)(categorical) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–4 | Low Risk | Score ≤4 |
| 4.5–7.5 | Intermediate Risk | Score 4.5-7.5 |
| 8–13 | High Risk | Score ≥8 |
Evidence-Based References (EBM)
- Janssens HJ, Fransen J, van de Lisdonk EH, van Riel PL, van Weel C, Janssen M. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med. 2010 Jul 12;170(13):1120-6. doi: 10.1001/archinternmed.2010.196.DOI: 10.1001/archinternmed.2010.196
- Kienhorst LB, Janssens HJ, Fransen J, Janssen M. The validation of a diagnostic rule for gout without joint fluid analysis: a prospective study. Rheumatology (Oxford). 2015 Apr;54(4):609-14. doi: 10.1093/rheumatology/keu378.DOI: 10.1093/rheumatology/keu378
Related calculators
- Disease Activity Score-28 for Rheumatoid Arthritis with CRP (DAS28-CRP)
- Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR)
- Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis
- ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria
- ACR/EULAR Gout Classification Criteria